- Home
- QSI vs CRMD Comparison
QSI vs CRMD Comparison
Compare QSI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- CRMD
- Stock Information
- Founded
- QSI 2013
- CRMD 2006
- Country
- QSI United States
- CRMD United States
- Employees
- QSI N/A
- CRMD 82
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- QSI Health Care
- CRMD Health Care
- Exchange
- QSI Nasdaq
- CRMD Nasdaq
- Market Cap
- QSI 226.8M
- CRMD 865.2M
- IPO Year
- QSI N/A
- CRMD 2010
- Fundamental
- Price
- QSI $1.54
- CRMD $11.69
- Analyst Decision
- QSI Strong Buy
- CRMD Strong Buy
- Analyst Count
- QSI 3
- CRMD 8
- Target Price
- QSI $2.38
- CRMD $17.57
- AVG Volume (30 Days)
- QSI 5.6M
- CRMD 4.6M
- Earning Date
- QSI 11-11-2025
- CRMD 10-29-2025
- Dividend Yield
- QSI N/A
- CRMD N/A
- EPS Growth
- QSI N/A
- CRMD N/A
- EPS
- QSI N/A
- CRMD 0.79
- Revenue
- QSI $3,412,000.00
- CRMD $121,484,498.00
- Revenue This Year
- QSI N/A
- CRMD $404.81
- Revenue Next Year
- QSI $219.33
- CRMD $56.11
- P/E Ratio
- QSI N/A
- CRMD $14.00
- Revenue Growth
- QSI 100.47
- CRMD 14970.29
- 52 Week Low
- QSI $0.61
- CRMD $5.60
- 52 Week High
- QSI $5.77
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- QSI 68.53
- CRMD 40.84
- Support Level
- QSI $1.24
- CRMD $11.08
- Resistance Level
- QSI $1.16
- CRMD $13.83
- Average True Range (ATR)
- QSI 0.10
- CRMD 0.81
- MACD
- QSI 0.06
- CRMD -0.28
- Stochastic Oscillator
- QSI 85.67
- CRMD 15.21
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.